Skip to content

Feasibility Study of Sleep Endoscopy Under Hypnosis in a Sleep Center

Feasibility Study of Sleep Endoscopy Under Hypnosis in a Sleep Center

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05091164
Acronym
DISE
Enrollment
23
Registered
2021-10-25
Start date
2021-02-08
Completion date
2021-06-30
Last updated
2021-10-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Drug Induce Sleep Endoscopy, Hypnosis, Obstructive Sleep Apnea Syndrome

Brief summary

It is proposed to induce in a obstructive sleep apnea syndrome patient, a hypnotic trance leading to intense muscle relaxation, capable of reproducing in the upper airways (VAS) the muscle relaxation observed in sleep, at the origin of obstructive apnea and snoring. The collapsibility type obtained, classified according to Kezirian, will allow specific management by OAM in the event of predominant anteroposterior stenosis. There are no risks fort the patient. The Drug Induce Sleep endoscopy (DISE) is a fibroscopy of upper aerodigestive tract.

Interventions

PROCEDUREDrug induce sleep endoscopy of upper aerodigestive tract under hypnosis

Drug induce sleep endoscopy of upper aerodigestive tract under hypnosis.

Sponsors

European Clinical Trial Experts Network
CollaboratorOTHER
Polyclinique Poitiers
CollaboratorUNKNOWN
Elsan
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SCREENING
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient, women or men over 18 years old * Moderate obstructive sleep apnea syndrome (Hypopnea apnea index between 15 and 30) without any serious sign * Simple Ronchopathy * Indication of video-fibroscopy of upper airways * Affiliated subject or beneficiary of a social security scheme * Patient having signed the free and informed consent

Exclusion criteria

* Psychiatric disorders that can be decompensated by hypnosis (bipolarity, schizophrenia, ...) * Smoking less than 10 cigarettes per day * Alcoholism, chronic or serious disabling pathology * Medical history of cancer of upper airways, radiotherapy * Pregnancy * Recent supper airway infection, rhinosinusitis * Active allergy * Non-obstructive sleep apnea syndrome * severe non-obstructive sleep apnea syndrome (Hypopnea apnea index\> 30) * Dental contraindication to mandibular advancement device * Intolerance or allergy to local anesthesia with Xylocaine spray 5% known * Refusal to participate in the study * Protected patients: adults under guardianship, curatorship or other legal protection, deprived of liberty by judicial or administrative decision * Pregnant, breastfeeding or parturient woman * Hospitalized without consent

Design outcomes

Primary

MeasureTime frameDescription
proportion of patients for whom the DISE could be performed in good conditions of comfort45 daysThe good conditions of comfort for the patient, the operator and the healthcare professional trained in hypnosis will be evaluated using a comfort scale with 4 subscales of 5 items, rated from 1 to 4, in Likert scale from 1 (not at all satisfied) to 4 (very satisfied), i.e. for each subscale a sub-score between 5 and 20 and an overall score between 20 and 80. * Patient comfort * Physical comfort (5 items) * Psychological comfort (5 items) * Practitioner comfort o For the realization of the DISE (5 items) * Comfort of the health professional trained in hypnosis o For the realization of hypnosis (5 items) It will be considered that the DISE could have been carried out in good conditions of comfort (for the patient, the operator and the healthcare professional trained in hypnosis), if the overall score is ≥60 AND no sub-score n 'is \<10.

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026